Beta Bionics Inc. Common Stock (BBNX)

About BBNX

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

420

Website

www.betabionics.com

Fundamentals

1-day range

$19.36$20.38

Market cap

$634.80M

P/E (trailing)

—

P/E (forward)

-8.59

EPS (trailing)

$-1.60

Dividend yield

—

Beta

—

Avg. volume

1.14M

Forecasts

11 analyst ratings

Beta Bionics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• BBNX

  Beta Bionics Inc. Common Stock

  $19.72

  ▲ 0.92%
  Market cap $634.80MP/E —
  $8.8$32.71
• BWAY

  BrainsWay Ltd. American Depositary Shares

  $14.29

  ▼ 0.76%
  Market cap $626.52MP/E 72.19
  $2,391$5,123
• TCMD

  Tactile Systems Technology Inc. Common Stock

  $23.15

  ▲ 0.17%
  Market cap $650.97MP/E 26.91
  $12.91$37.77
• MDXG

  MiMedx Group Inc Common Stock

  $4.49

  ▼ 0.44%
  Market cap $609.28MP/E 98.12
  $3.03$7.97
• KIDS

  OrthoPediatrics Corp. Common Stock

  $23.67

  ▲ 1.50%
  Market cap $549.03MP/E —
  $14.42$26.74
• SSII

  SS Innovations International Inc. Common Stock

  $3.5

  ▲ 2.34%
  Market cap $742.49MP/E —
  $3.11$10
• NPCE

  Neuropace Inc. Common Stock

  $14.41

  ▲ 1.98%
  Market cap $473.90MP/E —
  $8.76$19.6

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Beta Bionics, Inc. 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 7/31/2026

• Stephen Feider · June 29, 2026 · Option Exercise

  4.9K @ $5.1
• Stephen Feider · June 29, 2026 · Sale

  4.9K @ $17.03
• Stephen Feider · June 26, 2026 · Option Exercise

  5.1K @ $5.1
• Stephen Feider · June 26, 2026 · Sale

  5.1K @ $17.05
• Mark Hopman · June 24, 2026 · Sale

  1.3K @ $15.01
• Christy Jones · June 24, 2026 · Sale

  1.4K @ $15
• Mark Hopman · June 4, 2026 · Sale

  275 @ $12.31
• Christy Jones · June 4, 2026 · Sale

  2.8K @ $14
• Steven Jon Russell · June 2, 2026 · Sale

  4.2K @ $12.61
• Sean Saint · June 2, 2026 · Sale

  16.9K @ $12.61
• Stephen Feider · June 2, 2026 · Sale

  6.7K @ $12.61
• Mike Mensinger · June 2, 2026 · Sale

  4.4K @ $12.61
• Mark Hopman · June 2, 2026 · Sale

  5.3K @ $12.61
• Adam Lezack · May 22, 2026 · Sale

  998 @ $11.21
• Christy Jones · May 21, 2026 · Grant

  17.0K

Institutional Ownership

March 31, 2026

Total shares held

48.55M

Total value held

$486.76M

Institutional holders

127